Evaluating alternative cannabis regimes

被引:86
作者
MacCoun, R
Reuter, P
机构
[1] Univ Calif Berkeley, Goldman Sch Publ Policy, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Boalt Hall Sch Law, Berkeley, CA 94720 USA
[3] Univ Maryland, Sch Publ Affairs, College Pk, MD 20742 USA
[4] Univ Maryland, Dept Criminol, College Pk, MD 20742 USA
[5] RAND Corp, Drug Policy Res Ctr, Santa Monica, CA 90406 USA
关键词
D O I
10.1192/bjp.178.2.123
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Cannabis policy continues to be controversial in North America, Europe and Australia. Aims To inform this debate, we examine alternative legal regimes for controlling cannabis availability and use. Method We review evidence on the effects of cannabis depenalisation in the USA, Australia and The Netherlands. We update and ex tend our previous (MacCoun & Reuter, 1997) Empirical comparison of cannabis prevalence statistics in the USA,The Netherlands and other European nations. Results The available evidence indicates that depenalisation of the possession of small quantities of cannabis does not increase cannabis prevalence. The Dutch experience suggests that commercial promotion and sales may significantly increase cannabis prevalence Conclusions Alternatives to an aggressively enforced cannabis prohibition are feasible and merit serious consideration. A model of depenalised possession and personal cultivation has many of the advantages of outright legalisation with few of its risks.
引用
收藏
页码:123 / 128
页数:6
相关论文
共 26 条
[1]  
Abraham Manja D., 1999, LICIT ILLICIT DRUG U
[2]  
ADLAF EM, 1995, ONTARIO STUDENT DRUG
[3]   Explaining recent increases in students' marijuana use: Impacts of perceived risks and disapproval, 1976 through 1996 [J].
Bachman, JG ;
Johnston, LD ;
O'Malley, PM .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (06) :887-892
[4]  
Cohen P., 1996, CANNABIS USE STEPPIN
[5]  
Cohen PDA, 1998, CANNABIS USE AMSTERD
[6]  
DEZWART WM, 1997, KERNGEGEVENS ROKEN D
[7]  
DRIESSEN FMH, 1989, TIJDSCHR ALCOHOL DRU, V15, P2
[8]  
*EUR MON CTR DRUGS, 1997, ANN REP STAT DRUGS P
[9]  
Hall W, 1997, ADDICTION, V92, P1109
[10]  
Hartnoll R., 1994, MULTICITY STUDY DRUG